Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation

NCT03821883 is registered in ClinicalTrials.gov with Xinhua Hospital, Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT03821883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03821883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation
Lead sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2020
Completion date
December 1, 2024
Enrollment
1,120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, bleeding, stroke